Abstract: A method and system of project publishing are disclosed. In one embodiment, a method includes generating self publishing services associated with a project, generating automated publishing services associated with the project, generating advanced publishing optimization services associated with the project, and generating post publishing tracking services associated with the project. The project may include a book, a periodical, an audio book, advertising copy, a screenplay, a newsletter, music, a video file, and/or an audio file.

Abstract: A method and system of community-based project content creation are disclosed. In one embodiment, a method includes generating user profiles, associating first user with a first user profile, generating project profiles, each project profile associated with at least one user profile, associating the first user with a first project profile, designating a privilege level associated with a second user profile, and generating as online project collaboration between the first project profile and the second user profile based on the privilege level. The method may also include generating community building activities. The method may also include personalizing the first user profile. The method may further include generating a search associated with the user profiles and/or the project profiles. In addition, the method may include generating a post-publishing activity associated.

Abstract: This disclosure provides a system for qualifying embryonic stem cells intended for human therapy. A comprehensive sequencing project has identified important markers that are characteristic of undifferentiated pluripotent cells. Combinations of these markers have been used to screen feeder cells, media additives, and culture conditions that promote rapid expansion of stem cells without differentiation. By measuring undifferentiated stem cell markers, and markers formed by early progenitors such as stromal cells, the user can quantitate the proportion and extent of differentiation. This establishes standardized criteria for master cell banks and cell cultures that can then be used to produce therapeutic cell populations and medicaments for use in regenerative medicine.